SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-008796
Filing Date
2023-06-23
Accepted
2023-06-23 12:27:43
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-61963.html 4  
1 PRIMARY DOCUMENT marketforms-61963.xml 4 4123
  Complete submission text file 0001214659-23-008796.txt   5577
Mailing Address ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
MORRIS TIMOTHY E (Reporting) CIK: 0001191286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 231036406

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations